Company
Last deal
$18.1M
Local Amount - GBP 23.7M
Amount
Series B
Stage
16.08.2021
Date
6
all rounds
$44.1M
Total amount
General
About Company
Ultromics is an AI-powered diagnostic aid that helps cardiologists improve the diagnosis of coronary heart disease by more than 90%.
Industry
Sector :
Subsector :
Keywords :
founded date
01.01.2017
Number of employees
Company Type
For Profit
Last funding type
Series B
IPO status
Private